107 related articles for article (PubMed ID: 20881372)
21. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
22. [Malignant mesothelioma: study of prognostic factors in a series of 188 cases].
Viallat JR; Boutin C; Rey F; Astoul P; Farisse P
Arch Anat Cytol Pathol; 1993; 41(5-6):205-11. PubMed ID: 8135581
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors in cases of diffuse malignant pleural mesothelioma].
Umeki S; Kawai S; Hino J; Adachi M; Yagi S; Soejima R
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jul; 27(7):768-76. PubMed ID: 2810965
[TBL] [Abstract][Full Text] [Related]
24. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.
Kao SC; Pavlakis N; Harvie R; Vardy JL; Boyer MJ; van Zandwijk N; Clarke SJ
Clin Cancer Res; 2010 Dec; 16(23):5805-13. PubMed ID: 20956618
[TBL] [Abstract][Full Text] [Related]
25. [Malignant pleural mesothelioma. A diagnostic and therapeutic challenge].
Aliaga JL; Román A; Rodríguez E; Buges J; Montane M; Puig X
An Med Interna; 1993 Sep; 10(9):446-8. PubMed ID: 8218802
[TBL] [Abstract][Full Text] [Related]
26. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
27. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
[TBL] [Abstract][Full Text] [Related]
28. [Clinical masks of pleural mesothelioma].
Shchennikov EL; Rybkis AI
Ter Arkh; 1993; 65(4):86-8. PubMed ID: 8059416
[No Abstract] [Full Text] [Related]
29. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
30. Immunoperoxidase staining of malignant cells in pleural effusions.
Pastormerlo M
Pathologica; 1990; 82(1080):421-5. PubMed ID: 2284143
[TBL] [Abstract][Full Text] [Related]
31. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
Yan TD; Boyer M; Tin MM; Sim J; Kennedy C; McLean J; Bannon PG; McCaughan BC
Ann Thorac Surg; 2009 May; 87(5):1552-6. PubMed ID: 19379903
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma.
Tanrikulu AC; Abakay A; Komek H; Abakay O
Environ Health Prev Med; 2016 Sep; 21(5):304-311. PubMed ID: 27068290
[TBL] [Abstract][Full Text] [Related]
33. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery.
Nakas A; Martin-Ucar AE; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2008 Feb; 33(2):303-6. PubMed ID: 18155556
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma.
O'Kane SL; Cawkwell L; Campbell A; Lind MJ
Eur J Cancer; 2005 Jul; 41(11):1645-8. PubMed ID: 15964184
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of osteopontin expression in malignant pleural mesothelioma.
Cappia S; Righi L; Mirabelli D; Ceppi P; Bacillo E; Ardissone F; Molinaro L; Scagliotti GV; Papotti M
Am J Clin Pathol; 2008 Jul; 130(1):58-64. PubMed ID: 18550471
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in patients with breast cancer and malignant pleural effusion.
van Galen KP; Visser HP; van der Ploeg T; Smorenburg CH
Breast J; 2010; 16(6):675-7. PubMed ID: 21070453
[No Abstract] [Full Text] [Related]
37. Prognostic factors in patients presenting with pleural effusion revealing malignancy.
Anevlavis S; Kouliatsis G; Sotiriou I; Koukourakis MI; Archontogeorgis K; Karpathiou G; Giatromanolaki A; Froudarakis ME
Respiration; 2014; 87(4):311-6. PubMed ID: 24457947
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
[TBL] [Abstract][Full Text] [Related]
40. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak G; Metintaş M; Yildirim H; Metintaş S; Dündar E; Erginel S; Alataş F
Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
